Wearable device to control blood pressure using magnetic flux
An Updated Wearable Magnetic Flux Device to Optimize Blood Pressure Control
NA · National Heart Centre Singapore · NCT05866445
This study is testing a wearable device that uses magnetic fields to see if it can help people with high blood pressure and those with normal blood pressure manage their levels better without medications.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 21 Years to 80 Years |
| Sex | All |
| Sponsor | National Heart Centre Singapore (other) |
| Locations | 1 site (Singapore) |
| Trial ID | NCT05866445 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of a wearable magnetic flux device on blood pressure control in both hypertensive and normotensive individuals. It aims to assess the safety and efficacy of static magnetic flux as a non-invasive treatment option for hypertension. Participants will wear a blood pressure monitoring device and complete questionnaires, allowing researchers to compare outcomes between the two groups. The goal is to enhance patient compliance with blood pressure management by providing an alternative to traditional medications.
Who should consider this trial
Good fit: Ideal candidates include individuals with controlled hypertension or normotensive individuals within specified blood pressure ranges.
Not a fit: Patients with severely uncontrolled hypertension, recent changes in blood pressure medications, or certain medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could offer a non-invasive and effective method for managing blood pressure, potentially improving adherence among patients who struggle with medication.
How similar studies have performed: While the use of magnetic flux for blood pressure control is a novel approach, similar non-pharmacological interventions have shown promise in improving hypertension management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * For normotensive patients, Systolic Blood Pressure 100-139mmHg/ Diastolic Blood Pressure 50-89mmHg * For hypertensive patients, SBP 140-180mmHg, DBP 90-110mmHg (no change in blood pressure medications in last one month) OR Hypertensive patients with stable blood pressure (SBP not \<100, DBP not \<50) well controlled on medication Exclusion Criteria * SBP \<100mmHg, DBP\<50mmHg * SBP\>180mmHg, DBP \>110mmHg * Recent change (\<1month) in blood pressure medications * Prior stroke * Prior ischemic heart disease * Prior peripheral vascular heart disease * Prior carotid stenosis or bruit * Presence of metallic implants (e.g. ICD, pacemaker, etc) * Pregnancy * Breast feeding * Allergy to device material/skin allergy
Where this trial is running
Singapore
- National Heart Centre Singapore — Singapore, Singapore (RECRUITING)
Study contacts
- Principal investigator: Jie Sheng Foo, M.D. — National Heart Centre Singapore
- Study coordinator: Jie Sheng Foo, M.D.
- Email: foo.jie.sheng@singhealth.com.sg
- Phone: 67048961
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hypertension